Trials / Terminated
TerminatedNCT04280354
Molecular Biomarkers for Sepsis
Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia (sCAP)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center observational case-control study in Intensive Care Unit (ICU) patients is to identify novel biomarkers allowing to recognize severe community acquired pneumonia (sCAP) -associated sepsis at an earlier stage and predict sepsis-related mortality. Patients with sCAP (cases) will be profoundly characterized over time regarding the development of sepsis and compared with control patients. The mechanisms and influencing factors on the clinical course will be explored with most modern -omics technologies allowing a detailed characterisation. These data will be analysed using machine learning algorithms and multi-dimensional mathematical models.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | compare data patterns by data-driven algorithms to determine sepsis | compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis |
| OTHER | compare data patterns by data-driven algorithms to predict sepsis-related mortality | compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality |
Timeline
- Start date
- 2022-02-16
- Primary completion
- 2022-07-31
- Completion
- 2022-07-31
- First posted
- 2020-02-21
- Last updated
- 2024-05-09
Locations
15 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04280354. Inclusion in this directory is not an endorsement.